Concepedia

Author

Katina Robison

Women & Infants Hospital of Rhode IslandORCID

Also Known As

K Robison, K. Robison, K.M. Robison, Katina M Robison, Katina M. Robison, Katina Robison, Leslie Randall

174

Publications

2.2K

Citations

22

H-Index

79

Concepts

All Affiliations

Women & Infants Hospital of Rhode IslandBrown UniversityProvidence CollegeRoswell Park Comprehensive Cancer CenterHartford Hospital
KR

About

Katina Robison is an author at Women & Infants Hospital of Rhode Island specializing in medicine, obstetrics, and gynecology oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

16

21

1K

2

Public Health

6

6

222

3

Health Sciences

2

2

48

4

Education

1

1

12

5

Nursing

1

1

18

Katina Robison

×

31

Publications

1.7K

Citations

20

H-Index

YearCitations

Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39)

Kathleen N. Moore, Michael A. Bookman, Jalid Sehouli,

Journal of Clinical Oncology

2021

376

Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass

Richard G. Moore, Moune Jabre-Raughley, Amy Brown,

American Journal of Obstetrics and Gynecology

2010

353

Adherence patterns to National Comprehensive Cancer Network (NCCN) guidelines for referral to cancer genetic professionals

T. Febbraro, Katina Robison, Jennifer Scalia Wilbur,

Gynecologic Oncology

2015

116

Adjuvant Gemcitabine Plus Docetaxel Followed by Doxorubicin Versus Observation for High-Grade Uterine Leiomyosarcoma: A Phase III NRG Oncology/Gynecologic Oncology Group Study

Martee L. Hensley, Danielle Enserro, Helen Hatcher,

Journal of Clinical Oncology

2018

85

Gender Differences in Scholarly Productivity Within Academic Gynecologic Oncology Departments

Emily K. Hill, Rachel A. Blake, Jenna Emerson,

Obstetrics and Gynecology

2015

69

Utility of Tumor Marker HE4 to Predict Depth of Myometrial Invasion in Endometrioid Adenocarcinoma of the Uterus

Richard G. Moore, Craig Miller, Amy Brown,

International Journal of Gynecological Cancer

2011

66

Isolated sentinel lymph node dissection with conservative management in patients with squamous cell carcinoma of the vulva: A prospective trial

Richard G. Moore, Katina Robison, Amy Brown,

Gynecologic Oncology

2008

61

Long-term follow-up of vulvar cancer patients evaluated with sentinel lymph node biopsy alone

Katina Robison, Dario R. Roque, Carolyn K. McCourt,

Gynecologic Oncology

2014

57

Adherence Patterns to National Comprehensive Cancer Network Guidelines for Referral of Women With Breast Cancer to Genetics Professionals

Ashley Stuckey, T. Febbraro, Jessica Laprise,

American Journal of Clinical Oncology

2014

48

LBA31 Primary results from IMagyn050/GOG 3015/ENGOT-OV39, a double-blind placebo (pbo)-controlled randomised phase III trial of bevacizumab (bev)-containing therapy +/- atezolizumab (atezo) for newly diagnosed stage III/IV ovarian cancer (OC)

Kathleen N. Moore, Michael A. Bookman, Jalid Sehouli,

Annals of Oncology

2020

35

Page 1